Clinical Trials
2 trialsNCT02711202 2026-04-13
Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation
Institute for Clinical and Experimental Medicine
Phase NA Completed
NCT03011268 2025-05-31
BIOSTOP
Helse Møre og Romsdal HF
Phase NA Completed